AAPL313.39+2.73 (+0.88%) ▲|ABBV252.74-1.91 (-0.75%) ▼|ABT95.18-0.66 (-0.69%) ▼|ACN137.19-4.95 (-3.48%) ▼|ADBE220.94-0.60 (-0.27%) ▼|AMAT570.50+16.00 (+2.89%) ▲|AMD517.41+1.30 (+0.25%) ▲|AMGN367.99-0.11 (-0.03%) ▼|AMT165.04-0.21 (-0.13%) ▼|AMZN243.62-2.36 (-0.96%) ▼|AVGO388.69+17.91 (+4.83%) ▲|AXP336.39-13.19 (-3.77%) ▼|BA224.95-6.73 (-2.90%) ▼|BAC58.30-1.56 (-2.61%) ▼|BKNG174.29-7.66 (-4.21%) ▼|BLK990.34-19.09 (-1.89%) ▼|BMY57.54-0.43 (-0.74%) ▼|BNY150.14-2.77 (-1.81%) ▼|BRK-B494.79-9.21 (-1.83%) ▼|C137.39-3.38 (-2.40%) ▼|CAT948.08+7.96 (+0.85%) ▲|CL93.04-1.99 (-2.09%) ▼|CMCSA23.19-0.22 (-0.94%) ▼|COF191.95-10.94 (-5.39%) ▼|COP110.72+2.28 (+2.10%) ▲|COST953.13+5.63 (+0.59%) ▲|CRM166.58-2.94 (-1.73%) ▼|CSCO113.82+2.03 (+1.82%) ▲|CVS104.47+0.14 (+0.13%) ▲|CVX175.97+1.96 (+1.13%) ▲|DE596.74-6.87 (-1.14%) ▼|DHR190.77-3.42 (-1.76%) ▼|DIS96.70-0.78 (-0.80%) ▼|DUK126.79-1.43 (-1.12%) ▼|EMR136.48-1.43 (-1.04%) ▼|FDX309.76-3.12 (-1.00%) ▼|GD374.31-0.33 (-0.09%) ▼|GE356.03-10.95 (-2.98%) ▼|GEV1,070.99-6.09 (-0.57%) ▼|GILD135.82-0.54 (-0.40%) ▼|GM76.24+0.21 (+0.28%) ▲|GOOG358.71-4.91 (-1.35%) ▼|GOOGL361.92-5.11 (-1.39%) ▼|GS1,029.64-13.34 (-1.28%) ▼|HD336.21-9.00 (-2.61%) ▼|HON220.36-4.69 (-2.08%) ▼|IBM302.05-4.08 (-1.33%) ▼|INTC110.24-0.15 (-0.14%) ▼|INTU272.10-9.07 (-3.23%) ▼|ISRG415.10-12.20 (-2.86%) ▼|JNJ263.40-3.84 (-1.44%) ▼|JPM330.62-8.60 (-2.54%) ▼|KO83.40-0.65 (-0.77%) ▼|LIN527.67-10.56 (-1.96%) ▼|LLY1,215.83-19.73 (-1.60%) ▼|LMT527.96-7.42 (-1.39%) ▼|LOW212.85-8.05 (-3.64%) ▼|LRCX333.15+7.02 (+2.15%) ▲|MA519.86-11.76 (-2.21%) ▼|MCD278.25-3.96 (-1.40%) ▼|MDLZ59.48-0.74 (-1.23%) ▼|MDT82.01-1.82 (-2.17%) ▼|META603.12-12.46 (-2.02%) ▼|MMM154.70-3.31 (-2.09%) ▼|MO72.81-0.15 (-0.21%) ▼|MRK125.99-2.87 (-2.23%) ▼|MS218.07-3.97 (-1.79%) ▼|MSFT383.34-5.50 (-1.41%) ▼|MU948.80+10.42 (+1.11%) ▲|NEE87.44-1.03 (-1.16%) ▼|NFLX75.59-0.59 (-0.77%) ▼|NKE42.89-0.32 (-0.74%) ▼|NOW107.78-2.95 (-2.66%) ▼|NVDA204.12+7.19 (+3.65%) ▲|ORCL140.49-1.11 (-0.78%) ▼|PEP142.51-2.47 (-1.70%) ▼|PFE24.05-0.02 (-0.08%) ▼|PG148.40-4.35 (-2.85%) ▼|PLTR132.22-2.15 (-1.60%) ▼|PM187.07-0.72 (-0.38%) ▼|QCOM186.56+3.59 (+1.96%) ▲|RTX194.91-5.94 (-2.96%) ▼|SBUX103.87+0.26 (+0.25%) ▲|SCHW101.70-0.23 (-0.23%) ▼|SO96.38-0.91 (-0.94%) ▼|SPG219.09-8.10 (-3.57%) ▼|T21.12+0.03 (+0.14%) ▲|TMO510.13-6.49 (-1.26%) ▼|TMUS180.14-4.59 (-2.48%) ▼|TSLA394.06-8.84 (-2.19%) ▼|TXN301.32+8.02 (+2.73%) ▲|UBER73.60-0.73 (-0.98%) ▼|UNH425.60-2.59 (-0.60%) ▼|UNP280.94-2.18 (-0.77%) ▼|UPS109.94-2.02 (-1.80%) ▼|USB61.00-1.89 (-3.01%) ▼|V347.53-4.67 (-1.33%) ▼|VZ42.45-0.14 (-0.33%) ▼|WFC85.56-1.62 (-1.86%) ▼|WMT113.10+1.56 (+1.40%) ▲|XOM141.13-0.56 (-0.40%) ▼|AAPL313.39+2.73 (+0.88%) ▲|ABBV252.74-1.91 (-0.75%) ▼|ABT95.18-0.66 (-0.69%) ▼|ACN137.19-4.95 (-3.48%) ▼|ADBE220.94-0.60 (-0.27%) ▼|AMAT570.50+16.00 (+2.89%) ▲|AMD517.41+1.30 (+0.25%) ▲|AMGN367.99-0.11 (-0.03%) ▼|AMT165.04-0.21 (-0.13%) ▼|AMZN243.62-2.36 (-0.96%) ▼|AVGO388.69+17.91 (+4.83%) ▲|AXP336.39-13.19 (-3.77%) ▼|BA224.95-6.73 (-2.90%) ▼|BAC58.30-1.56 (-2.61%) ▼|BKNG174.29-7.66 (-4.21%) ▼|BLK990.34-19.09 (-1.89%) ▼|BMY57.54-0.43 (-0.74%) ▼|BNY150.14-2.77 (-1.81%) ▼|BRK-B494.79-9.21 (-1.83%) ▼|C137.39-3.38 (-2.40%) ▼|CAT948.08+7.96 (+0.85%) ▲|CL93.04-1.99 (-2.09%) ▼|CMCSA23.19-0.22 (-0.94%) ▼|COF191.95-10.94 (-5.39%) ▼|COP110.72+2.28 (+2.10%) ▲|COST953.13+5.63 (+0.59%) ▲|CRM166.58-2.94 (-1.73%) ▼|CSCO113.82+2.03 (+1.82%) ▲|CVS104.47+0.14 (+0.13%) ▲|CVX175.97+1.96 (+1.13%) ▲|DE596.74-6.87 (-1.14%) ▼|DHR190.77-3.42 (-1.76%) ▼|DIS96.70-0.78 (-0.80%) ▼|DUK126.79-1.43 (-1.12%) ▼|EMR136.48-1.43 (-1.04%) ▼|FDX309.76-3.12 (-1.00%) ▼|GD374.31-0.33 (-0.09%) ▼|GE356.03-10.95 (-2.98%) ▼|GEV1,070.99-6.09 (-0.57%) ▼|GILD135.82-0.54 (-0.40%) ▼|GM76.24+0.21 (+0.28%) ▲|GOOG358.71-4.91 (-1.35%) ▼|GOOGL361.92-5.11 (-1.39%) ▼|GS1,029.64-13.34 (-1.28%) ▼|HD336.21-9.00 (-2.61%) ▼|HON220.36-4.69 (-2.08%) ▼|IBM302.05-4.08 (-1.33%) ▼|INTC110.24-0.15 (-0.14%) ▼|INTU272.10-9.07 (-3.23%) ▼|ISRG415.10-12.20 (-2.86%) ▼|JNJ263.40-3.84 (-1.44%) ▼|JPM330.62-8.60 (-2.54%) ▼|KO83.40-0.65 (-0.77%) ▼|LIN527.67-10.56 (-1.96%) ▼|LLY1,215.83-19.73 (-1.60%) ▼|LMT527.96-7.42 (-1.39%) ▼|LOW212.85-8.05 (-3.64%) ▼|LRCX333.15+7.02 (+2.15%) ▲|MA519.86-11.76 (-2.21%) ▼|MCD278.25-3.96 (-1.40%) ▼|MDLZ59.48-0.74 (-1.23%) ▼|MDT82.01-1.82 (-2.17%) ▼|META603.12-12.46 (-2.02%) ▼|MMM154.70-3.31 (-2.09%) ▼|MO72.81-0.15 (-0.21%) ▼|MRK125.99-2.87 (-2.23%) ▼|MS218.07-3.97 (-1.79%) ▼|MSFT383.34-5.50 (-1.41%) ▼|MU948.80+10.42 (+1.11%) ▲|NEE87.44-1.03 (-1.16%) ▼|NFLX75.59-0.59 (-0.77%) ▼|NKE42.89-0.32 (-0.74%) ▼|NOW107.78-2.95 (-2.66%) ▼|NVDA204.12+7.19 (+3.65%) ▲|ORCL140.49-1.11 (-0.78%) ▼|PEP142.51-2.47 (-1.70%) ▼|PFE24.05-0.02 (-0.08%) ▼|PG148.40-4.35 (-2.85%) ▼|PLTR132.22-2.15 (-1.60%) ▼|PM187.07-0.72 (-0.38%) ▼|QCOM186.56+3.59 (+1.96%) ▲|RTX194.91-5.94 (-2.96%) ▼|SBUX103.87+0.26 (+0.25%) ▲|SCHW101.70-0.23 (-0.23%) ▼|SO96.38-0.91 (-0.94%) ▼|SPG219.09-8.10 (-3.57%) ▼|T21.12+0.03 (+0.14%) ▲|TMO510.13-6.49 (-1.26%) ▼|TMUS180.14-4.59 (-2.48%) ▼|TSLA394.06-8.84 (-2.19%) ▼|TXN301.32+8.02 (+2.73%) ▲|UBER73.60-0.73 (-0.98%) ▼|UNH425.60-2.59 (-0.60%) ▼|UNP280.94-2.18 (-0.77%) ▼|UPS109.94-2.02 (-1.80%) ▼|USB61.00-1.89 (-3.01%) ▼|V347.53-4.67 (-1.33%) ▼|VZ42.45-0.14 (-0.33%) ▼|WFC85.56-1.62 (-1.86%) ▼|WMT113.10+1.56 (+1.40%) ▲|XOM141.13-0.56 (-0.40%) ▼|
23 C
New York
Thursday, July 9, 2026

Tag: development

METABORA GAMES Forms Strategic Web3 Game Partnership with Baligames

METABORA GAMES Begins Co-Development of Web3 Game with Promising Studio Baligames, best known for 'Axie Champions'New Hybrid Title to Combine Casual Match-3 Puzzle Mechanics...

METABORA GAMES Forms Strategic Web3 Game Partnership with Baligames

METABORA GAMES Begins Co-Development of Web3 Game with Promising Studio Baligames, best known for 'Axie Champions'New Hybrid Title to Combine Casual Match-3 Puzzle Mechanics...

METABORA GAMES Forms Strategic Web3 Game Partnership with Baligames

METABORA GAMES Begins Co-Development of Web3 Game with Promising Studio Baligames, best known for 'Axie Champions'New Hybrid Title to Combine Casual Match-3 Puzzle Mechanics...

Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer

HONG KONG, July 23, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been...

Xinhua Silk Road: China’s TISCO leads green and low-carbon development in steel industry

BEIJING, July 23, 2025 /PRNewswire/ -- In recent years, Taiyuan Iron and Steel (Group) or TISCO, a subsidiary of China Baowu Steel Group Corporation,...

Xinhua Silk Road: China’s TISCO leads green and low-carbon development in steel industry

BEIJING, July 23, 2025 /CNW/ -- In recent years, Taiyuan Iron and Steel (Group) or TISCO, a subsidiary of China Baowu Steel Group Corporation,...

Orla Mining Reports Pit Wall Event at Camino Rojo

VANCOUVER, BC, July 23, 2025 /CNW/ - Orla Mining Ltd. (TSX: OLA; NYSE: ORLA) ("Orla" or the "Company") reports that an uncontrolled material movement...

Xinhua Silk Road: Datong rises as premier global tourism destination with 240-hour visa-free transit policy

BEIJING, July 24, 2025 /PRNewswire/ -- Datong, located in north China's Shanxi Province, is fast becoming a premier cultural destination for international travelers. In...

Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million

Carlsbad, CA, July 23, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced an agreement between the Company and several accredited investors to exercise certain existing warrants (the “Existing Warrants”) to purchase up to an aggregate of 4,318,905 shares of common stock. The Existing Warrants had adjusted exercise prices of $1.40 and were issued by the Company on May 10, 2022; February 1, 2024; May 6, 2024; and December 13, 2024, with each exercise occurring at a reduced exercise price of $0.9047 per share.

Genomma Lab Internacional Announces Results for the Second Quarter 2025

MEXICO CITY, July 23, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

HEADWATER EXPLORATION INC. ANNOUNCES SECOND QUARTER OPERATING AND FINANCIAL RESULTS AND DECLARES QUARTERLY DIVIDEND

CALGARY, AB, July 23, 2025 /CNW/ - Headwater Exploration Inc. (the "Company" or "Headwater") (TSX: HWX) is pleased to announce its operating and financial results for the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment